Clinical TrialsTeva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Teva Advances TEV-‘408 to Phase 2b After Early Vitiligo Trial Shows R... Read Post »
Clinical TrialsHengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Hengrui and Kailera’s Oral GLP-1 HRS-7535 Delivers Up to 11.1% Weight... Read Post »
Clinical TrialsTvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Tvardi Reports Positive Phase 1 Results for Oral STAT3 Inhibitor TTI-109 Read Post »
Clinical TrialsItalfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Italfarmaco Reports New Phase 3 EPIDYS MRI Data Showing Givinostat Preserve... Read Post »
Health TidingsNanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in... NanoViricides Advances NV-387 Toward Phase II Trial for Bundibugyo Ebola in... Read Post »
Health TidingsChina Accepts Astellas’ PADCEV Plus Keytruda Filing for Muscle-Invasi... China Accepts Astellas’ PADCEV Plus Keytruda Filing for Muscle-Invasi... Read Post »
Health TidingsFDA Accepts Organogenesis’ ReNu® BLA for Symptomatic Knee Osteoarthr... FDA Accepts Organogenesis’ ReNu® BLA for Symptomatic Knee Osteoarthr... Read Post »
Health Tidings Mergers & AcquisitionsVertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Vertex to Acquire Crinetics for $10 Billion, Adding PALSONIFY and Phase 3 A... Read Post »
New Drug ApprovalEU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... EU Approves TEPKINLY Plus R2 as New Chemotherapy-Free Option for Follicular... Read Post »
Clinical TrialsTG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... TG Therapeutics Launches Phase 2 Trial of BRIUMVI in Treatment-Resistant Sc... Read Post »
GenericsGlenmark Launches Generic Olanzapine for Injection in the US, Expanding Ins... Glenmark Launches Generic Olanzapine for Injection in the US, Expanding Ins... Read Post »
ResearchExperimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Experimental IDH1 Vaccine Shows Encouraging 8-Year Survival in IDH-Mutant A... Read Post »
New Drug ApprovalMHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... MHRA Approves Incyte’s Retifanlimab for Advanced Merkel Cell Carcinom... Read Post »
Health Tidings Mergers & AcquisitionsAstex Signs Breast Cancer Drug Discovery Deal with Genentech Astex Signs Breast Cancer Drug Discovery Deal with Genentech Read Post »
Health TidingsImmuron Engages Pullan Consulting to Drive IMM-529 Commercial Partnership Immuron Engages Pullan Consulting to Drive IMM-529 Commercial Partnership Read Post »
Clinical TrialsOpus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Opus Genetics Aligns with FDA on Phase 3 Trial Design for OPGx-LCA5 Read Post »
Clinical TrialsFDA Accepts Pharvaris’ Deucrictibant NDA for HAE FDA Accepts Pharvaris’ Deucrictibant NDA for HAE Read Post »
Drugs Safety AlertInvivyd Plans Full FDA Approval for COVID-19 as PEMGARDA EUA Faces 2027 Exp... Invivyd Plans Full FDA Approval for COVID-19 as PEMGARDA EUA Faces 2027 Exp... Read Post »
Health TidingsCelea Raises $180 Million to Launch Phase 3 SURPASS-IPF Trial of Deupirfeni... Celea Raises $180 Million to Launch Phase 3 SURPASS-IPF Trial of Deupirfeni... Read Post »
Health TidingsAscletis Files Dual FDA INDs for Ultra‑Long‑Acting Obesity Therapies Ta... Ascletis Files Dual FDA INDs for Ultra‑Long‑Acting Obesity Therapies Ta... Read Post »
Health Tidings Mergers & AcquisitionsNovartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Novartis Acquires Myricx Bio to Advance Novel ADC Payload Technology Read Post »
ResearchBeyond the Needle: How Oral Drug Delivery Is Redefining Modern Medicine Beyond the Needle: How Oral Drug Delivery Is Redefining Modern Medicine Read Post »
ResearchHow ADCs and Bispecific Antibodies Are Transforming Cancer Treatment How ADCs and Bispecific Antibodies Are Transforming Cancer Treatment Read Post »
ResearchWhy PD-1 Remains the Leading Target in Cancer Immunotherapy Why PD-1 Remains the Leading Target in Cancer Immunotherapy Read Post »
Clinical TrialsIndian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Indian Researchers at Tata Memorial Centre Show Papaya Leaf Extract Improve... Read Post »
Health TidingsMHRA Calls for Faster Regulation to Accelerate Medical Innovation MHRA Calls for Faster Regulation to Accelerate Medical Innovation Read Post »
New Drug ApprovalMHRA Conditionally Approves Wegovy for MASH MHRA Conditionally Approves Wegovy for MASH Read Post »
Health TidingsNewron Maps FDA Path Forward for Evenamide Phase 3 Trial Newron Maps FDA Path Forward for Evenamide Phase 3 Trial Read Post »
Health TidingsCincinnati Children’s Phase 2 Trial Shows WRSs2 Shigella Vaccine Achi... Cincinnati Children’s Phase 2 Trial Shows WRSs2 Shigella Vaccine Achi... Read Post »
Health TidingsNature Publication Strengthens Arcus’ Casdatifan Program in Advanced ... Nature Publication Strengthens Arcus’ Casdatifan Program in Advanced ... Read Post »
New Drug ApprovalMHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... MHRA Authorises Inqlexzo Gemcitabine Delivery System for BCG-Unresponsive H... Read Post »
Clinical TrialsWHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... WHO Launches PARTNERS Trial to Evaluate MBP134 and Remdesivir for Bundibugy... Read Post »
Clinical TrialsBrii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Brii Bio Reports Phase 2b Data Supporting Sequential BRII-179 Regimen for F... Read Post »
Health TidingsFDA Issues Complete Response Letter to Ascelia Pharma’s Orviglance ND... FDA Issues Complete Response Letter to Ascelia Pharma’s Orviglance ND... Read Post »
Clinical TrialsCould a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Could a Once-Daily Polypill Improve Heart Failure Outcomes? POLY-HF Trial S... Read Post »
Health Tidings Mergers & AcquisitionsArcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher ... Read Post »
GenericsEMA Expands Lupin’s NaMuscla Approval to Include Children with Non-Dystro... EMA Expands Lupin’s NaMuscla Approval to Include Children with Non-Dystro... Read Post »
Clinical TrialsNeurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Neurocrine Moves Crinecerfont into Phase 2 Trial for Children Under 4 with ... Read Post »
Health Tidings Mergers & AcquisitionsTakeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Takeda Partners With Insilico Medicine in AI Drug Discovery Deal Worth Up t... Read Post »
Health Tidings Regulatory & Health Policy Women & Child HealthEMA Moves to Embed Women’s Health Across Europe’s Medicines Reg... EMA Moves to Embed Women’s Health Across Europe’s Medicines Reg... Read Post »
Health Tidings Mergers & AcquisitionsUnited Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... United Therapeutics Acquires Thymmune to Expand T-Cell Regeneration Researc... Read Post »
Health TidingsJCO Study Supports FDA Approval of BIZENGRI in NRG1+ Cholangiocarcinoma JCO Study Supports FDA Approval of BIZENGRI in NRG1+ Cholangiocarcinoma Read Post »
Clinical TrialsAcoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Acoramidis Associated with First-Ever Early and Sustained Direct Kidney-Pro... Read Post »
Clinical TrialsRevolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Revolution Medicines Reports Promising Phase 1/2 Results for Zoldonrasib Co... Read Post »
Health TidingsMHRA Starts Evaluation of Eisai’s Lemborexant for Adult Insomnia MHRA Starts Evaluation of Eisai’s Lemborexant for Adult Insomnia Read Post »
Clinical TrialsRoche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Roche’s Divarasib Shows Superiority in Head-to-Head Phase III Trial A... Read Post »
Health TidingsAbbisko, AstraZeneca Partner to Advance Oral PD-L1 Inhibitor and Tagrisso C... Abbisko, AstraZeneca Partner to Advance Oral PD-L1 Inhibitor and Tagrisso C... Read Post »
New Drug ApprovalEU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... EU Approves Novartis’ Itvisma as First Gene Replacement Therapy for C... Read Post »
New Drug ApprovalHUTCHMED Secures Third Approved Indication in China for ORPATHYS HUTCHMED Secures Third Approved Indication in China for ORPATHYS Read Post »
New Drug ApprovalFDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT FDA Approves CASGEVY for Children Aged 2 and Older With SCD and TDT Read Post »
